Inscobee Inc. - 12 May 2025 SCHEDULE 13D Report for Apimeds Pharmaceuticals US, Inc. Common Stock (APUS)

Filing Manager: Inscobee Inc.
Reporting Manager: Apimeds Inc.
Security: Apimeds Pharmaceuticals US, Inc. Common Stock
Symbol: APUS
Shares outstanding: 11,577,066 shares
Disclosed Ownership: 4,387,708 shares
Ownership: 38%
Form type: SCHEDULE 13D
Filing time: 19 May 2025, 21:29:56 UTC
Date of event: 12 May 2025
Next filing: 26 Jan 2026
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Inscobee Inc.	18%	2,028,657	2,028,657	0	/s/ Jakap Koo	Jakap Koo, Chief Executive Officer	0002057997
Apimeds Inc.	38%	4,387,708	4,387,708	0	/s/ Jakap Koo	Jakap Koo, Chief Executive Officer